PACKAGE LEAFLET: INFORMATION FOR THE USER
1.3.1. Package Leaflet 2 - if you are immobile for a great part of the day Talk to your doctor before taking this product if any of the above apply to you.
Information, User, Leaflet, Packages, Package leaflet, Information for the user
Download PACKAGE LEAFLET: INFORMATION FOR THE USER
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
PACKAGE LEAFLET - Medicines
www.medicines.org.ukPage 2 of 7 Package leaflet: Information for the patient Zopiclone 7.5 mg Film-coated Tablets (zopiclone) Read all of this leaflet carefully before you …
Related documents
Packaging ‘blue-box’ requirements and additional ...
www.hma.euDanish text required in the package leaflet Section 8, Dosage for each species, route(s) and method of administration Please notice that your veterinarian may
Scientific guidelines with SmPC recommendations
www.ema.europa.euScientific guidelines with SmPC recommendations EMA/813125/2012 Page 3/5 . Guidelines Reference to specific SmPC section(s) Evaluation of the pharmacokinetics of medicinal products in
M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS …
www.merck.com3 Women of childbearing age should be advised not to become pregnant for 3 months after vaccination and should be informed of the reasons for this precaution.
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukFor practical information about using Orlistat Mylan 60 mg capsules, hard, patients should read the package leaflet or contact their doctor or pharmacist.
Assessment, Report, Public, Procedures, Leaflet, Packages, Public assessment report decentralised procedure, Decentralised, Package leaflet
GUIDELINES FOR SUBMITTING APPLICATION FOR …
www.ich.org2 table of contents i. abbreviations ii. foreword iii. introduction iv. glossary 1. application form for registration and marketing of a medicine in the sadc region 1 2.
Compilation of QRD decisions on stylistic matters …
www.ema.europa.euNot always understood, particularly in the package leaflet. The approach varies across languages, so acronyms/abbreviations may be either in the
Decision, Matter, Leaflet, Packages, Package leaflet, Stylistic, Qrd decisions on stylistic matters
International Package Leaflet - COARTEM
www.coartem.comNovartis Page 4 International Package Leaflet 02-Nov-12 amend 12-Dec-12 Coartem Treatment and stand-by emergency treatment The treatment should be administered at the time of initial diagnosis or at onset of symptoms.
International, Leaflet, Packages, International package leaflet
Public Assessment Report - GOV.UK
www.mhra.gov.ukFor practical information about using Calcium gluconate 10% w/v Solution for injection, patients should read the package leaflet or contact their doctor or pharmacist.
Assessment, Report, Public, Leaflet, Packages, Package leaflet, Public assessment report
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1/6 Package leaflet: Information for the user REVAXIS® Suspension for injection in pre-filled syringe Diphtheria, Tetanus and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
Information, User, Leaflet, Packages, Package leaflet, Information for the user